The effects of SK&F 86002 and other pyridinyl imidazole compounds on m
urine cytokine production were investigated. In vitro, SK&F 86002 inhi
bited LPS stimulated TNF-alpha production by the RAW 264.7 cell line a
nd by oil elicited peritoneal macrophages with an IC50 of 5 muM. In ge
neral, the activity was reflective of previous results obtained with h
uman monocytes as SK&F 86002 and its analogs demonstrated identical ra
nk order potency for TNF-alpha inhibition in both species. These compo
unds also inhibited TNF-alpha in vivo in a murine model of endotoxin s
hock. Following oral administration, SK&F 86002 and its analogs reduce
d serum TNF-alpha levels by > 80% and afforded 100% protection from le
thality. In contrast, tenidap, a novel anti-inflammatory drug, had min
imal to no effect on murine TNF-alpha production in the same assays. T
hese data further extend the pharmacological profile of the pyridinyl
imidazoles by demonstrating that these compounds potently inhibit muri
ne TNF-alpha production both in vitro and in vivo.